Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features
- PMID: 2938706
- PMCID: PMC1491035
Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features
Abstract
Percutaneous transluminal coronary angioplasty (PTCA) has been used clinically for 8 years and is becoming widely accepted in the treatment of atherosclerotic coronary artery disease. Since the long-term effects of the procedure are unknown, the rate of restenosis following the procedure, approximately 30%, is of major concern. We briefly review the current status of PTCA and the effect of angioplasty on the vessel wall and discuss proposed mechanisms of recurrent stenosis.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources